First Header Logo Second Header Logo

Search Results (101)

MatchTypeWhy
Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment.Academic Article Why?
Characterization of the interleukin-1beta-converting enzyme/ced-3-family protease, caspase-3/CPP32, in Hodgkin's disease: lack of caspase-3 expression in nodular lymphocyte predominance Hodgkin's disease.Academic Article Why?
A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma.Academic Article Why?
ACR appropriateness criteria follow-up of Hodgkin lymphoma.Academic Article Why?
ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II.Academic Article Why?
ACR Appropriateness Criteria® Hodgkin Lymphoma-Unfavorable Clinical Stage I and II.Academic Article Why?
ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma.Academic Article Why?
CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET.Academic Article Why?
Curing Hodgkin's lymphoma: quantity and quality.Academic Article Why?
Effect of race on the outcome of pediatric patients with Hodgkin's lymphoma.Academic Article Why?
Endobronchial presentation of Hodgkin lymphoma: a review of the literature.Academic Article Why?
Hepatocellular carcinoma developing years after extended field radiation for Hodgkin's lymphoma.Academic Article Why?
Monoclonal IgH gene rearrangement in microdissected nodules from nodular sclerosis Hodgkin disease.Academic Article Why?
Patterns and timing of initial relapse in patients subsequently undergoing transplantation for Hodgkin's lymphoma.Academic Article Why?
Polypoid endobronchial Hodgkin lymphoma with an initial response to photodynamic therapy.Academic Article Why?
Per Page    Page  of 7last Nextnext
Prev
Search Criteria
  • Hodgkin Lymphoma
Filter by Type
_
Click "Why?" to see why an item matched the search.